MedTrace Logo

Lumbar Interbody Implant Study

NCT04418830 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1050

Last updated 2025-12-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of NuVasive interbody implants when used during thoracic and/or lumbar spine surgery as measured by reported complications, radiographic outcomes, and patient-reported outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of these interbody implants.

Conditions

  • Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Degenerative Scoliosis
  • Spinal Stenosis
  • Sagittal Deformity

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kyle Malone, MS · Globus Medical

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2025-12-31
Completion
2026-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418830 on ClinicalTrials.gov